Per Falholt

Per Falholt is chairman of the board at Universe, he has been chairman of the board at the Danish Technical University (DTU) since 2013, and is also a board member at Danfoss. Per Falholt is the founder of Per Falholt Global R&D Advisory Services. He was executive vice president at Novozymes, Research & Development from 2000 to 2016, senior vice president at Novo Nordisk from 1999-2000 and director at Novo Nordisk from 1991 to 1999. As Chief Scientific Officer at Novozymes, Mr. Falholt helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer’s needs and support growth. Mr. Falholt holds a MSc in chemical engineering from Technical University of Denmark. He was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010-2014.

Position	Member of the board since 2016
Year of Birth	1958
Holding of shares in Cytovac AB (as of Dec 31, 2020)	36,000
Other ongoing assignments	Chairman of the board of Universe A/S, DHI Foundation, Ferm Biotics A/S och DTU A/S. Board member of Danfoss A/S and Novo Nordisk Foundation. Owner of Per Falholt Global R&D Advisory A/S.
Previous Assignments (within the last 5 years)	Board member of DHI A/S. Leading position at Novozymes A/S.
Independent in relation to the company and its management	Yes
Independent in relation to larger shareholders	Yes